HBM Healthcare Investments (Cayman) Ltd.
CIK 1232258 · last filed 2023-02-16
HBM Healthcare Investments (Cayman) Ltd. is a corporate insider who has filed 54 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for MLYS, was dated Feb 16, 2023. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $311.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$311.06M
9
54
-$16.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | 10%+ Owner | 3,218,106 | $23.62 | $76.01M | $5.00M | 1 | 2023-02-16 |
| IO Biotech, Inc. (IOBT) Delisted | 10%+ Owner | 2,365,545 | $0.05 | $113.5K | $4.55M | 1 | 2021-11-12 |
| HOWL | 10%+ Owner | 625,995 | $0.38 | $238.5K | $0 | 1 | 2021-05-05 |
| Nabriva Therapeutics plc (NBRV) Delisted | 10%+ Owner | 2,334,128 | $1.42 | $3.31M | -$4.13M | 15 | 2017-09-14 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | 10%+ Owner | 1,757,680 | $2.23 | $3.92M | -$632.9K | 1 | 2015-06-01 |
| PTCT | 10%+ Owner | 2,441,504 | $75.14 | $183.45M | $8.73M | 2 | 2013-12-19 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 2,806,937 | — | — | $5.02M | 1 | 2013-10-03 |
| PCRX | 10%+ Owner | 2,233,993 | $22.99 | $51.36M | -$27.84M | 4 | 2013-03-25 |
| MICRUS ENDOVASCULAR CORP (MEND) Delisted | 10%+ Owner | 1,635,403 | — | — | -$7.06M | 24 | 2010-03-04 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-16 | MLYS | Mixed | +3,218,106 | $5.00M | EDGAR |
| 2021-11-12 | IO Biotech, Inc. (IOBT) Delisted | Mixed | +2,690,545 | $4.55M | EDGAR |
| 2021-05-05 | HOWL | Conv (C) | +625,995 | $0 | EDGAR |
| 2017-09-14 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −36,608 | -$313.4K | EDGAR |
| 2017-09-05 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −639 | -$6.1K | EDGAR |
| 2017-08-09 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −19,803 | -$207.9K | EDGAR |
| 2017-08-01 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −6,585 | -$69.2K | EDGAR |
| 2017-07-26 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −160 | -$1.7K | EDGAR |
| 2017-07-24 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −44,231 | -$464.4K | EDGAR |
| 2017-07-21 | — | Sell (S) | −44,231 | -$464.4K |